Summary
Vincent J. Angotti, chief executive officer of Talphera, Inc. (NASDAQ:TLPH), reported purchasing 213,310 shares of common stock on March 13, 2026, at $0.586 per share, for a total outlay of $124,999. The purchase was disclosed in a Form 4 filing with the Securities and Exchange Commission and was executed as part of a previously announced private investment in public equity (PIPE) transaction.
Transaction details and holdings
The reported acquisition adds to Angotti’s stake in the company. After the PIPE transaction, his direct ownership totals 800,705 shares, which includes 10,000 shares obtained through the company’s Employee Stock Purchase Plan. The stated purchase price of $0.586 represents an approximate 27% discount to the current quoted share price of $0.80. Talphera’s market capitalization stands at $37.35 million, while its stock has fallen about 30% on a year-to-date basis.
Context from company disclosures and recent results
The Form 4 filing identifies this purchase as part of the previously announced PIPE. Separately, Talphera reported fourth-quarter results that coincided with a notable drop in its share price following an update that the company would delay completion of its Nephro CRRT study. During the company’s earnings call, management stressed both its strong cash position and ongoing progress across clinical programs.
Company commentary and the filing together frame a mixed signal: management highlights financial stability and forward movement in trials, while the announced study delay appears to have been a material driver of recent investor concern and the stock’s pullback.
Where investors can find more analysis
The company’s financials and deeper analytical coverage are referenced as available through a Pro Research Report on InvestingPro for those seeking more comprehensive due diligence. Investors remain attentive to Talphera’s clinical timelines and any further updates to funding or study progress.
Note on limitations
The information above is drawn from the company’s regulatory filing and its published quarterly disclosures. Where details are limited in those documents, this report reflects the available statements rather than additional interpretation.